Skip to main content

eMed

Category: AI in Healthcare

A digital healthcare platform pioneering the 'Test-to-Treat' model by combining at-home diagnostic testing with live-proctored verification and immediate AI-driven telehealth services. eMed was founded in 2020. The company is led by Dr. Patrice Harris. Based in Miami, USA. Team size: 500+. Total funding raised: $200.0M. Latest round: Series A ($200.0M, Mar 2024). Key investors include ["Aon","Tom Brady (TB Ventures)","Linda Yaccarino"].

Founded
2020
Headquarters
Miami, USA
Team size
500+
Total funding
$200.0M

Value proposition

Democratizes access to clinical-grade healthcare by enabling users to test, receive verified results, and obtain prescriptions from home in minutes, significantly reducing the time-to-treatment for acute and chronic conditions.

Products and solutions

["Digital 'Test-to-Treat' Platform (Acute care for COVID-19, Flu, Strep, UTI)","AI-Powered Weight Management Program (GLP-1 clinical support and monitoring)","Live-Proctored At-Home Diagnostic Kits","eMed UK / GP at Hand (Digital-first primary care services)","Chronic Care Management Dashboard"]

Unique value

Pioneered the first virtually proctored at-home testing platform that meets regulatory standards for clinical validity, bridging the gap between home convenience and laboratory-grade reliability.

Target customer

Individual consumers, large employers, health insurance providers, and government health systems (e.g., UK NHS).

Industries served

["Telehealth","HealthTech & Digital Health","Diagnostics","Pharmaceuticals","Public Health"]

Technology advantage

Integrates proprietary real-time proctoring software with Babylon Health’s legacy AI triage and digital-first primary care infrastructure to create a full-stack healthcare delivery engine.

How they differentiate

Proprietary live-proctoring technology that ensures clinical validity for at-home diagnostics, enabling a seamless 'Test-to-Treat' model with immediate telehealth intervention.

Main competitors

["LetsGetChecked","Ro","Everlywell"]

Key partnerships

["Abbott (Partnership for BinaxNOW rapid tests)","National Health Service (NHS) UK","Aon (Strategic investment and distribution)","Quest Diagnostics (Laboratory integration)"]

Notable customers

["National Health Service (NHS) UK","Abbott","Aon"]

Major milestones

["Pioneered the first virtually proctored at-home COVID-19 test in 2020","Acquired Babylon Health's UK assets (including GP at Hand) in September 2023","Secured $200M Series A funding at a $2B+ valuation in March 2024","Launched AI-driven weight management and chronic care programs in 2024"]

Growth metrics

Achieved a valuation of over $2 billion; expanded workforce to 500+ employees following the acquisition of Babylon Health's UK operations.

Market positioning

Full-stack digital health platform bridging the gap between at-home diagnostic testing and immediate clinical care/pharmacy services.

Geographic focus

United States, United Kingdom

Patents and IP

Holds proprietary IP related to remote proctoring technology and digital verification of rapid diagnostic tests (specific patent filings are generally held under eMed Digital Health).

About Dr. Patrice Harris

Dr. Patrice Harris is a board-certified psychiatrist and a trailblazing healthcare leader who served as the 174th President of the American Medical Association (AMA), becoming the first African American woman to hold the position. Her career spans clinical practice, public health leadership as the Director of Health Services for Fulton County, Georgia, and extensive advocacy in healthcare policy. At eMed, she has led the company's evolution from a COVID-19 testing leader into a comprehensive AI-driven chronic care and weight management platform.

Official website: